Table 2. Predictive factors for the response of IV steroid treatment by logistic regression analysis performed using backward stepwise procedures.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 0.947 | 0.902–0.955 | 0.030 | 0.918 | 0.856–0.985 | 0.017 |
Gender, men | 0.795 | 0.253–2.502 | 0.696 | |||
Body mass index, kg/m2 | 1.041 | 0.834–1.301 | 0.721 | |||
Duration of GO, mon | 0.991 | 0.957–1.026 | 0.612 | |||
Smoking | 1.591 | 0.523–4.873 | 0.413 | |||
Sum of EOM, mm | 1.020 | 0.905–1.148 | 0.749 | 1.163 | 0.973–1.389 | 0.096 |
TSH, µIU/mL | 0.972 | 0.820–1.153 | 0.743 | |||
Free T4, ng/dL | 0.814 | 0.353–1.877 | 0.629 | |||
Pretreatment TBII, IU/L | 0.952 | 0.908–0.997 | 0.038 | 0.921 | 0.864–0.982 | 0.012 |
Changes of TBII for 12 wk | 0.959 | 0.901–1.021 | 0.193 | |||
Total cholesterol, mg/dL | 0.993 | 0.979–1.007 | 0.320 | |||
MRD1, mm | 1.171 | 0.809–1.694 | 0.404 | |||
Proptosis, mm | 1.139 | 0.944–1.374 | 0.174 | |||
Diplopia | 1.360 | 0.458–4.042 | 0.580 | |||
NOSPECS Class II, ≥ b | 4.846 | 0.540–43.464 | 0.159 | 7.204 | 0.544–95.386 | 0.134 |
CAS, ≥ 4 | 1.983 | 0.652–6.031 | 0.227 |
IV = intravenous, CI = confidence interval, OR = odds ratio, GO = Graves' ophthalmopathy, EOM = extraocular muscle, TSH = thyroid stimulating hormone, TBII = thyrotropin binding inhibitory immunoglobulin, MRD = margin reflex distance, CAS = clinical activity score.